Vienna Visit
Dr. S. Bhaskaran, Dr. Rajiv Raman, Dr. Tarun Sharma and Mr. D. Senthil participated in the meeting organized by Eli Lilly Company at Vienna, Austria on January 27 & 28, 2005.
The Eli Lilly project is about using Protein Kinase C inhibitor (PKC-inhibitor), and oral drug: Ruboxystaurin Mesylate, 32 mg/day for 3 years and evaluating its role in minimizing the progression of non-clinical significant macular edema. Photographer, Mr. M. S. Krishna has been certified by the Wisconsin Photographic Reading Center for this project. European Optometrist Society has certified Mr. D Senthil. The project will start in India on March 10 and enrollment will be completed by October 2005, a follow-up by 2008 and results will be ready by 2009.









Comments